Developing an e‐learning tool for clinicians to take patient preferences into account in esophageal cancer treatment decision‐making

INTRODUCTION Shared decision-making (SDM) has gained much attention in health care policy. 1–3 SDM is especially recommended when patients face preference-sensitive decisions about their treatment. In particular, when the evidence for superiority of one treatment over another is not available, the b...

Full description

Saved in:
Bibliographic Details
Published inHealth science reports Vol. 6; no. 12; pp. e1725 - n/a
Main Authors Hermus, Merel, Wilk, Berend J., Dekker, Jan Willem T., Nieuwenhuijzen, Grard A. P., Rosman, Camiel, Timmermans, Liesbeth, Wijnhoven, Bas P. L., Zijden, Charlène J., Lanschot, J. Jan B., Busschbach, Jan J., Lagarde, Sjoerd M., Kranenburg, Leonieke W.
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.12.2023
John Wiley and Sons Inc
Wiley
Subjects
active surveillance
Cancer therapies
Decision making
Esophageal cancer
Health care policy
learning tool
Online instruction
Participation
patient preferences
Patients
Preferences
Research Letter
Surgeons
Surgery
Surveillance
treatment decision‐making
esophageal cancer
learning tool
treatment decision‐making
active surveillance
patient preferences
Online AccessGet full text

Cover

More Information
Summary:INTRODUCTION Shared decision-making (SDM) has gained much attention in health care policy. 1–3 SDM is especially recommended when patients face preference-sensitive decisions about their treatment. In particular, when the evidence for superiority of one treatment over another is not available, the best treatment choice depends on how individuals value the risks and benefits of various treatment options- as is the case in esophageal cancer care. 4–6 The standard treatment for patients with potentially curable advanced esophageal cancer in large parts of the world is neoadjuvant chemoradiotherapy (nCRT) followed by surgery. 7 Within the Dutch multicenter Surgery As Needed for Oesophageal cancer (SANO)-trial, overall survival after standard surgery is compared to an active surveillance approach. [...]one of the deliverables of the NOSANO-study was an e-learning for clinicians with the aim to help them counseling esophageal cancer patients by taking patient preferences on treatment into account. The theoretical part provided information about: the current standard management of esophageal cancer; current state of affairs regarding research into esophageal cancer treatments; the experimental active surveillance approach in esophageal cancer as well as in other cancers; and the relevance of SDM in this context.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2398-8835
2398-8835
DOI:10.1002/hsr2.1725